医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Colorcon Continues Investment in China – Helping Accelerate Pharmaceutical Formulation Development

2015年06月30日 AM12:31
このエントリーをはてなブックマークに追加


 

HARLEYSVILLE, Pa.

Colorcon officially opened a new technical service laboratory in Beijing, China on June 25, 2015. Located in the Beijing YiZhuang Biomedical Park, this technical centre is in a unique position to work closely with the pharmaceutical research community in the North China region.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20150629005931/en/

The official opening of Colorcon's new technical service laboratory in the Beijing YiZhuang Biomedic ...

The official opening of Colorcon’s new technical service laboratory in the Beijing YiZhuang Biomedical Park (Photo: Business Wire)

The Beijing lab is Colorcon’s 19th Technical Service facility, which are located strategically close to customer hubs around the world, and the second Colorcon laboratory in China. Equipped for research scale solid dose development, the laboratory provides specialist support to accelerate development and commercialization of robust, high quality pharmaceutical drug formulations. The staff of technical professionals support customers from initial product concept, to pilot scale trials through to final production and registration.

Simon Tasker, Managing Director, Colorcon NESEA, comments, “Investment in the Beijing facility reflects our view of the strategic significance of Northern China from a long-term growth perspective. It reinforces our commitment to providing best-in-class products and services through a network of laboratories positioned close to our customers. This service model approach is the unique value of Colorcon.”

Martti Hedman, CEO, Colorcon Inc. explains, “Since establishing Shanghai Colorcon Coating Technology Limited in 1993, Colorcon has continued to make strategic investments in China. We have established an excellent supply chain, with quality focus at the global and local level for the local manufacture of Opadry® film coatings. The facility, backed by Colorcon’s global supply network, ensures business continuity planning (BCP) that covers continuation of production and service. Colorcon has developed an organization in China to provide real-time support and consultancy, covering everything from R&D to production scale-up, process and formulation troubleshooting, as well as training and education. We are proud to work in partnership with our customers, and in doing so, develop strong long-term personal and professional relationships”.

Company Information

Colorcon leads in the development, supply and technical support of speciality excipients: formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our products and technologies are complemented by our extensive application data and value-added services to support all phases of solid oral dose design, development and manufacture. Colorcon has 9 manufacturing facilities, 19 technical service laboratories globally and over 1200 employees.

www.colorcon.com.

# # #

View source version on businesswire.com: http://www.businesswire.com/news/home/20150629005931/en/

CONTACT

Colorcon
Deborah J. Taylor
Global Marketing
Communications Manager
+44-1322-627234
djtaylor@colorcon.co.uk
or
Media
Richard
Hayhurst
Richard Hayhurst Associates
+44-7711-821527
Richard@richardhayhurstassociates.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent